What does the TIME study tell us about morning and evening dosing of antihypertensive medication?

Area of Science:

• Cardiovascular Medicine
• Clinical Trials
• Hypertension Management

Background:

• Hypertension is a leading risk factor for cardiovascular disease.
• Optimal timing for antihypertensive medication is debated, potentially impacting treatment efficacy.
• The TIME study investigated the effect of dosing time on cardiovascular outcomes in hypertensive patients.

Purpose of the Study:

• To determine if evening dosing of antihypertensives is superior to morning dosing for cardiovascular event prevention.
• To assess the impact of medication timing on major adverse cardiovascular events (MACE).

Main Methods:

• A prospective, randomised, open-label, blinded-endpoint clinical trial.
• Involved adults with hypertension using their usual antihypertensive medications.
• Participants were assigned to either morning or evening dosing schedules.

Main Results:

• No statistically significant difference in the primary endpoint of major adverse cardiovascular events between evening and morning dosing groups.
• Blood pressure control was similar between the two dosing groups.
• Adherence to medication was also comparable across both groups.

Conclusions:

• Current evidence does not support a routine change in antihypertensive dosing time from morning to evening.
• Dosing time of antihypertensives may not significantly influence major cardiovascular outcomes.
• Further research may be needed to explore specific patient subgroups or alternative dosing strategies.